Ethics and Policy in the Age of Genetics and Medicine
A presentation sponsored by the UC College of Medicine entitled Ethics and Policy in the Age of Genetics and Medicine will be given by Eric M. Meslin, PhD, director of the Indiana University Center for Bioethics, on Thursday, March 20, from 4-5 p.m. in Kresge Auditorium, UC College of Medicine Medical Sciences Building. Dr. Meslin is also a professor of medicine and molecular genetics at the Indiana University School of Medicine, and a professor of philosophy at the Indiana University School of Liberal Arts. He is also assistant dean for bioethics at the Indiana University School of Medicine.
Dr. Meslin came to Indiana University in July 2001 from the National Bioethics Advisory Commission (NBAC), where he had been executive director since 1998. NBAC was appointed by President Bill Clinton in 1995, and was charged with advising the White House and the federal government on a range of bioethics issues including cloning, stem cell research, international clinical trials, and genetic studies. Dr. Meslin received his PhD from the Bioethics Program in Philosophy at the Kennedy Institute of Ethics, Georgetown University in Washington, DC.
He has held academic positions at the University of Toronto and the University of Oxford. From 1996-98 he was program director for Bioethics Research in the Ethical, Legal, and Social Implications Research Program at the National Human Genome Research Institute in Bethesda, MD. He has been a consultant to the World Health Organization and he is co-editor of the Bioethics and Humanities Series published by Indiana University Press, and associate editor of the
Journal of Medical Ethics.
Dr. Meslin has authored or co-authored more than 75 articles and book chapters, including more than 30 publications in peer-reviewed literature, with most focusing on various topics in research ethics, clinical ethics, and health policy. This presentation is free and open to the public.
Related Stories
Can new research improve the safety of AI therapy for teens?
December 5, 2025
The University of Cincinnati's Stephen Rush joined WVXU's Cincinnati Edition for a discussion on the growing trend of young people turning to artificial intelligence for mental health support and therapy.
Student-designed AI platform aims to match patients to specific cancer support groups
December 5, 2025
The University of Cincinnati is launching a clinical trial testing a student-designed, machine-learning powered platform to match patients with cancer to support groups specifically tailored to their needs and concerns.
What would expanded access to GLP-1s mean for the obesity rate?
December 4, 2025
The World Health Organization recently issued its first guidance on GLP-1 medications for adults with obesity — recommending long-term, continuous use when clinically appropriate. Malti Vij, MD, University of Cincinnati adjunct associate professor in the College of Medicine's Department of Internal Medicine, appeared on Cincinnati Edition on 91.7 WVXU News to discuss GLP-1s and what expanded insurance coverage of the medications might mean for Americans.